ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Once versus twice daily aspirin after coronary bypass surgery: a randomized trial

Monday, March 20, 2017

Submitted by

Arie Blitz

Source

Source Name: Journal of Thrombosis and Haemostasis

Source URL: http://onlinelibrary.wiley.com/doi/10.1111/jth.13667/abstract

Author(s)

J.S. Paikin, J. Hirsh, J.S. Ginsberg, J.I. Weitz, N.C. Chan, R.P. Whitlock, G. Pare, J.W. Eikelboom

The authors randomized 68 patients undergoing CABG to three treatment groups:

ASA 81 mg QD
ASA 325 mg QD
ASA 162 mg BID

On the 4th day following CABG, the authors measured serum thromboxane B2 (TXB2) as an inverse surrogate for ASA effect. The order of TXB2 levels were as follows: 162 mg BID << 81 mg BID ≈ 81 mg QD. Thus, the optimal regimen, according to this small study, would be ASA 162 mg BID.